Westbridge Renewable Energy Corp. to Webcast Live at VirtualInvestorConferences.com February 9th
February 07, 2023 08:35 ET
|
Virtual Investor Conferences
TORONTO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Westbridge Renewable Energy Corporation (TSXV: WEB, OTCQX: WEGYF, FRA: PUQ), based in Toronto, Canada, develops best-in-class, utility-scale solar PV...
CytoDyn Announces Appointment of Additional Directors with Industry Experience
October 20, 2022 08:30 ET
|
CytoDyn Inc.
Stephen Simes career public biotech company CEO and Ryan Dunlap CFO with public biotech company experience join Board VANCOUVER, Wash., Oct. 20, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY)...
CytoDyn to Hold Webcast to Provide a Quarterly Company Update
September 19, 2022 08:30 ET
|
CytoDyn Inc.
VANCOUVER, Washington, Sept. 19, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential...
CytoDyn to Hold Webcast to Provide a Quarterly Company Update
June 22, 2022 08:30 ET
|
CytoDyn Inc.
VANCOUVER, Washington, June 22, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the...
Permex Petroleum Appoints Greg Montgomery as Chief Financial Officer and Announces Resignation of Director
May 10, 2022 15:00 ET
|
Permex Petroleum Corporation
VANCOUVER, British Columbia, May 10, 2022 (GLOBE NEWSWIRE) -- Permex Petroleum Corporation (CSE: OIL) (OTCQB: OILCF) (FSE: 75P) ("Permex" or the "Company"), a junior oil and gas company, announces...
CytoDyn to Hold Webcast to Provide Company Update
March 30, 2022 08:30 ET
|
CytoDyn Inc.
VANCOUVER, Washington, March 30, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with...
CytoDyn to Hold Webcast and Live Q/A on January 13
January 11, 2022 16:35 ET
|
CytoDyn Inc.
VANCOUVER, Washington, Jan. 11, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the...
Canoe Announces Changes to its Board of Directors and Management
December 22, 2021 10:06 ET
|
Canoe Mining Ventures Corp.
TORONTO, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Canoe Mining Ventures Corp. (TSXV:CLV) ("Canoe" or the “Company”) announces the resignations and retirements of co-founder Duane Parnham and Dr. Roger...
CytoDyn to Hold Webcast and Live Q/A on December 14
December 10, 2021 15:59 ET
|
CytoDyn Inc.
VANCOUVER, Washington, Dec. 10, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the...
CytoDyn Reminds Stockholders to Register 24 hours before November 24th Annual Meeting
November 16, 2021 14:00 ET
|
CytoDyn Inc.
Management Team Will Present on Company’s Strategy Going Forward VANCOUVER, Washington, Nov. 16, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage...